[Interferons and other cytokines in rheumatic diseases].
With the growth of rheumatic morbidity the spectrum of medicines for its management needs to be extended. Selected aspects of etiology and clinical course of rheumatic diseases are discussed with reference to prospects of their application for etiopathogenetic therapy.
Ospel'nikova
T P
TP
Egorova
O N
ON
Balabanova
R M
RM
Kozina
V I
VI
Ershov
F I
FI
D056704:Adaptive Immunity; D015551:Autoimmunity; D001424:Bacterial Infections / Q000150:complications; D016207:Cytokines / Q000502:physiology*; D006801:Humans; D007113:Immunity, Innate; D007372:Interferons / Q000502:physiology / Q000627:therapeutic use; D012216:Rheumatic Diseases / Q000188:drug therapy / Q000209:etiology / Q000276:immunology*; D014777:Virus Diseases / Q000150:complications
D016207:Cytokines; D007372:Interferons